IRIDEX Corporation (IRIX)
IRIX trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.8483
-8.69% on the day
Market cap
$14.9M
Nano cap
Revenue · 2025
$52.7M
+8.2% on 2024
Net income · 2025
-$4.4M
-8.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | IRIX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United States |
| IPO year | 1996 |
| SEC CIK | 0001006045 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $52.7M |
| Net income | -$4.4M |
| Operating income | -$2.6M |
| Net margin | -8.4% |
| Operating margin | -4.9% |
| Revenue growth | +8.2% |
| Cash | $6.0M |
| Total assets | $29.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-09-25 |
| Latest annual report | 10-K | 2026-04-02 |
| Latest quarterly / interim | 10-Q | 2026-08-18 |
| Latest current report | 8-K | 2026-09-02 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ITOC | iTonic Holdings Ltd | $3.94 | +10.06% | $28.8M |
| NDRA | ENDRA Life Sciences Inc. | $5.04 | -1.85% | $7.6M |
| QTI | QT Imaging Holdings Inc. | $2.45 | -5.77% | $35.9M |
| POCI | Precision Optics Corporation Inc. | $4.56 | -0.98% | $50.0M |
| VBIO | Valion Bio Inc. | $1.55 | -7.74% | $3.0M |
| ECOR | electroCore Inc. | $8.39 | -9.59% | $75.6M |
| OM | Outset Medical Inc. | $4.06 | +1.25% | $76.3M |
| NXL | Nexalin Technology Inc. | $2.64 | -21.43% | $2.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier